Title: Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20121001
Title: Orthosteric and allosteric drug binding sites in the Caenorhabditis elegans mgl-2 metabotropic glutamate receptor.
Journal: Neuropharmacology 20120901
Title: Involvement of metabotropic glutamate receptor 5 signaling in activity-related proliferation of adult hippocampal neural stem cells.
Journal: The European journal of neuroscience 20120801
Title: Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function.
Journal: Nature 20120613
Title: Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK/ERK pathway.
Journal: Neurochemical research 20120501
Title: Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration.
Journal: Neuropharmacology 20120301
Title: Mutations causing syndromic autism define an axis of synaptic pathophysiology.
Journal: Nature 20111201
Title: Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses.
Journal: The Journal of biological chemistry 20111007
Title: Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome.
Journal: The Journal of pharmacology and experimental therapeutics 20110901
Title: Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110301
Title: mGluR5 positive allosteric modulation enhances extinction learning following cocaine self-administration.
Journal: Behavioral neuroscience 20110201
Title: Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats.
Journal: Neurobiology of learning and memory 20110101
Title: mGluR5 positive modulators both potentiate activation and restore inhibition in NMDA receptors by PKC dependent pathway.
Journal: Journal of biomedical science 20110101
Title: Differential Modulation of Thresholds for Intracranial Self-Stimulation by mGlu5 Positive and Negative Allosteric Modulators: Implications for Effects on Drug Self-Administration.
Journal: Frontiers in pharmacology 20110101
Title: 4-aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators.
Journal: Bioorganic & medicinal chemistry letters 20101215
Title: Glutamatergic targets for enhancing extinction learning in drug addiction.
Journal: Current neuropharmacology 20101201
Title: The difference in effect of mGlu2/3 and mGlu5 receptor agonists on cognitive impairment induced by MK-801.
Journal: European journal of pharmacology 20100810
Title: Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade.
Journal: European journal of pharmacology 20100810
Title: MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?
Journal: Pharmacology, biochemistry, and behavior 20100401
Title: Effects of positive allosteric modulators on single-cell oscillatory Ca2+ signaling initiated by the type 5 metabotropic glutamate receptor.
Journal: Molecular pharmacology 20091201
Title: Positive allosteric modulation of mGluR5 receptors facilitates extinction of a cocaine contextual memory.
Journal: Biological psychiatry 20090415
Title: Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.
Journal: Neuropharmacology 20090101
Title: Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold.
Journal: Bioorganic & medicinal chemistry letters 20080715
Title: Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex.
Journal: Biological psychiatry 20071001
Title: Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.
Journal: Molecular pharmacology 20070501
Title: A novel class of positive allosteric modulators of metabotropic glutamate receptor subtype 1 interact with a site distinct from that of negative allosteric modulators.
Journal: Molecular pharmacology 20060801
Title: Substituent effects of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides on positive allosteric modulation of the metabotropic glutamate-5 receptor in rat cortical astrocytes.
Journal: Journal of medicinal chemistry 20060601
Title: Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia.
Journal: Current topics in medicinal chemistry 20060101
Title: A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators.
Journal: Molecular pharmacology 20051201
Title: A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models.
Journal: The Journal of pharmacology and experimental therapeutics 20050401
Title: Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo.
Journal: Journal of medicinal chemistry 20041118
Title: Kinney GG, et, al. A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models. J Pharmacol Exp Ther. 2005 Apr; 313(1):199-206.
